A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.
Clinical trial NCT00605280 · COMPLETED
Trial details
- NCT number
- NCT00605280
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2009-11-01
- Enrollment
- 317
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.